Difference between revisions of "WSI24-68-Case-4"
From MGH Learn Pathology
(Creating page) |
(Added status template) |
||
| Line 15: | Line 15: | ||
|basedOn=WSI24-68 | |basedOn=WSI24-68 | ||
|requisition=Lower GI tract slide session | |requisition=Lower GI tract slide session | ||
| − | |reasonCode=41 y.o. female with breast cancer on pembrolizumab. | + | |reasonCode=41 y.o. female with breast cancer on pembrolizumab. |
|occurrenceDateTime=2024-05-06 15:30:00-04:00 | |occurrenceDateTime=2024-05-06 15:30:00-04:00 | ||
|authoredOn=2024-04-03 20:26:26.008404+00:00 | |authoredOn=2024-04-03 20:26:26.008404+00:00 | ||
| Line 29: | Line 29: | ||
|reasonCode=H&E | |reasonCode=H&E | ||
|basedOn=WSI24-68-Case-4 | |basedOn=WSI24-68-Case-4 | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Jg67 | ||
| + | |authoredOn=2024-04-03 20:26:26.008404+00:00 | ||
}} | }} | ||
Latest revision as of 16:50, September 3, 2024
